For the first time, adoption of bidirectional interoperability between smart pumps and EMRs is high enough that we can provide an idea of what integration will be like. KLAS’ new report dives into research on organization satisfaction for specific smart pump and EMR vendor combinations.
We wrote this report with two primary groups in mind: pharmacy directors, who are responsible for the safe delivery of medications to patients, and nursing leaders, whose daily workflows are directly affected by smart pump technology. Through our research and analysis, we hope to help these groups navigate the change management necessary to adopt this technology and help increase patient safety.
Some individuals or organizations may be under the impression that a pump is a pump and that it doesn’t matter which one they get, so they might as well go with the vendor who has been working with pumps the longest. But we can see that certain combinations really do make a difference, and it is important for organizations to go with a company that fits their culture. Some smart pump vendors are more hands off, while others have more high-touch models. This report helps organizations hoping to better understand what they can expect from their smart pump and EMR integration.
Slow and Steady
Ever since KLAS’ first report on smart pump and EMR interoperability, we have seen slow and steady growth in this segment. The stalled adoption rate of this market has been a little surprising considering its direct correlation with patient safety and the number of organizations that have expressed the goal to achieve interoperability.
A key issue affecting growth is the cost of interoperability and the competing provider priorities. Smart pump and EMR interoperability is primarily being driven today by pump vendors and providers who value the safety benefits. The EMR vendors who do have functional bidirectional pump interoperability — Cerner and Epic, for example — tend to work with large health systems that are often on the cutting edge of new technology and patient safety.
We were happy to see that since our last report, smart pump and EMR interoperability has seen meaningful developments. There has been new traction with other vendors, such as Meditech and Allscripts, going live and new bidirectional pumps coming onto the market. It will also be interesting to see the growth of new interoperable sites like those of Baxter and Smiths.
Factors for Success (and Frustration)
As we’ve conducted our research, change management and organization-wide buy-in are two main themes that have emerged as telling factors of organizations’ satisfaction with smart pump technology. Organizations that strive for broad adoption — not just in one department or hospital, but across all of them — often report having more success. Yes, broad adoption is more complex and has more steps, it also offers a great deal of value, and those organizations are going to be more successful in the long run.
Organizations that do a limited rollout may not invest resources into training and Wi-Fi improvements that are essential to ensure successful adoption and problem mitigation with this technology.
Future of Interoperability
In this market, there is room for smart pump vendors to expand their interoperability. Possible developments could be made in real-time location tracking, alert management systems, and integration with other pharmacy systems. Also, no single pump vendor is currently the market leader for all three of the main kinds of pumps: large volume pumps, PCA pumps, and syringe pumps. A vendor with all three would be able to drive almost comprehensive adoption for all infusion types for their customers.
Many questions remain as to whether other pump vendors are going to be able to streamline the process to adopt this technology and build out more infusion workflows. Regardless, we will hopefully expect to see the same continual, steady growth in this market segment.
Read more about our research on customer satisfaction regarding the different smart pump and EMR vendor combinations in our full report.
This piece was co-written by Jackson Tate, Research Director, and Paul Warburton, Senior Market Research Analyst with KLAS.